The MILESTONE study: Improving Transition from Child to Adult Mental Health Care
- Conditions
- Psychiatric disorders10037176
- Registration Number
- NL-OMON46880
- Lead Sponsor
- The University of Warwick - Warwick Medical School
- Brief Summary
Trial is onging in other countries
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 428
Inclusion criteria of young people attending CAMHS (2.5.3. in protocol):
1. Provides valid written informed consent, or assent, if below the legal age of consent.
2. If age is within one year of reaching the transition boundary of their CAMHS during the trial recruitment period and, in exceptional cases, not more than 3 months older than the transition boundary.
3. Has a mental disorder defined by DSM-IV-TR, DSM-5 or ICD 10/11, or is under the regular care of CAMHS (if not yet diagnosed).
4. Has an IQ * 70 as ascertained by previous standardized assessment or diagnosed by clinician, or no indication of intellectual impairment.;Inclusion criteria of parents/carers (2.5.5. in protocol)
1. Only one parent/carer per young person can be recruited into the study, the aim being to engage the same individual throughout the study. If the latter is not possible, then the aim is to involve another parent/carer.
2. If the young person doesn*t live with his/her biological parent/s, then his/her carer will be involved. A carer may be the legal guardian or a partner or an older adult sibling, or another individual living with and/or providing regular support to the young person.
3. For young people under the legal age of consent, the parent/carer has to be the legal guardian of the young person.
4. Young person consents to parent/carer participation.
5. Parent/carer provides a valid written informed consent.;Inclusion criteria of clinicians/care providers (2.5.7 in protocol)
1. Is responsible for the main care for young person at CAMHS (and AMHS or other relevant service provider, if referral is made).
2. Provides a valid written informed consent.
Exclusion criteria of young people attending CAMHS (2.5.4. in protocol):
1. Does not provide valid written informed consent, or assent, if below the legal age of consent.
2. Is younger than a year before the transition boundary of their CAMHS.
3. Has intellectual impairment (IQ < 70) as ascertained by previous standardized assessment or diagnosed by clinician.
If no data on intellectual functioning are available (because it has never been assessed) then care coordinators will be asked to make a clinical judgement on intellectual impairment before baseline assessment takes place.
4. If not able to (or expected not to be able to) complete the questionnaires due to severe physical disabilities or language problems, even with assistance from family members or research assistant.
5. Service user in a secure forensic institution;Exclusion criteria of parents/carers (2.5.6. in protocol)
1. A parent/carer who does not live with and/or provide regular support to young person.
2. Young person does not provide consent for parent/carer participation.
3. Parent/carer does not provide a valid written consent.
4. If not able to (or expected not to be able to) complete the questionnaires due to severe physical disabilities or language problems, even with assistance from family members or research assistant.;Exclusion criteria of clinicians/care providers (2.5.8. in protocol)
1. Does not provide care for young person, or only provides intermittent care at CAMHS (and AMHS or other relevant service provider, if a referral is made).
2. Does not provide a valid written informed consent.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome measure:<br /><br>Mental health status assessed by Health of the Nation Outcome Scale for<br /><br>Children and Adolescents (HONOSCA). This outcome will provide information about<br /><br>the need for care. Clinician rated HONOSCA and HONOS are validated<br /><br>questionnaires. The measures will be completed by a trained MILESTONE RA at<br /><br>four time points taking into account all available sources of information<br /><br>(including the young person, parent/carer, relevant clinician and the medical<br /><br>records) to ensure accuracy of data.</p><br>
- Secondary Outcome Measures
Name Time Method